BASAGLAR KwikPen insulin glargine (rbe) 100 IU/mL solution for injection cartridge

Active ingredient:

Insulin glargine, Quantity: 100 IU/mg

Available from:

Eli Lilly Australia Pty Ltd

INN (International Name):

Insulin glargine

Pharmaceutical form:

Injection, solution

Composition:

Excipient Ingredients: dilute hydrochloric acid; glycerol; sodium hydroxide; water for injections; metacresol; zinc oxide

Administration route:

Subcutaneous

Units in package:

2, 5, 10, 1

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

Insulin glargine is an insulin analogue indicated for once-daily subcutaneous administration in the treatment of type 1 diabetes mellitus in adults and children and type 2 diabetes mellitus in adults who require insulin for the control of hypeglycaemia.

Product summary:

Visual Identification: Clear to colourless solution; Container Type: Cartridge; Container Material: Glass Type I Clear; Container Life Time: 2 Years; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Authorization status:

Licence status A

Authorization date:

2014-11-21